Pucotenlimab Clinical Trials
6 recruitingDrug
Phase 26Phase 12
Showing 1–6 of 6 trials
Recruiting
Phase 2
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck
Locally Advanced Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou106 enrolled1 locationNCT06959108
Recruiting
Phase 2
The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study
Salivary Gland Carcinomas
Ji Dongmei90 enrolled1 locationNCT07464366
Recruiting
Phase 2
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Colorectal Cancer (CRC)
Sun Yat-sen University50 enrolled1 locationNCT07448142
Recruiting
Phase 1Phase 2
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Pancreatic CancerPD-1 InhibitorPD-L1+2 more
Zhejiang Provincial People's Hospital10 enrolled1 locationNCT07312422
Recruiting
Phase 2
Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)
Rectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University68 enrolled1 locationNCT06770270
Recruiting
Phase 1Phase 2
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Pediatric CancerRhabdomyosarcoma
Sun Yat-sen University82 enrolled1 locationNCT06456892